These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11317061)

  • 21. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine.
    Traub SJ; Hoffman RS; Nelson LS
    J Urban Health; 2002 Dec; 79(4):549-55. PubMed ID: 12468674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
    Hanson KL; Luciana M
    J Clin Exp Neuropsychol; 2010 Apr; 32(4):337-49. PubMed ID: 20397296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of MDMA and methylphenidate on social cognition.
    Schmid Y; Hysek CM; Simmler LD; Crockett MJ; Quednow BB; Liechti ME
    J Psychopharmacol; 2014 Sep; 28(9):847-56. PubMed ID: 25052243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is ecstasy a drug of dependence?
    Degenhardt L; Bruno R; Topp L
    Drug Alcohol Depend; 2010 Feb; 107(1):1-10. PubMed ID: 19836170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.
    Harrington RD; Woodward JA; Hooton TM; Horn JR
    Arch Intern Med; 1999 Oct; 159(18):2221-4. PubMed ID: 10527300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylenedioxymethamphetamine (MDMA, "Ecstasy").
    Shannon M
    Pediatr Emerg Care; 2000 Oct; 16(5):377-80. PubMed ID: 11063374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecstasy intoxication: the toxicological basis for treatment.
    Ferigolo M; Machado AG; Oliveira NB; Barros HM
    Rev Hosp Clin Fac Med Sao Paulo; 2003; 58(6):332-41. PubMed ID: 14762493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
    Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK
    Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Speed users (metamphetamines): a return journey between ecstasy (MDMA) and cocaine. Clinical, preventive and health-care questions].
    Royo-Isach J; Magrané M; Velilla A; Ruiz L
    Aten Primaria; 2004 Dec; 34(10):553-6. PubMed ID: 15607059
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ecstasy].
    Ege PP
    Ugeskr Laeger; 2000 Jul; 162(31):4161-2. PubMed ID: 10962923
    [No Abstract]   [Full Text] [Related]  

  • 34. Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators.
    Vanattou-Saïfoudine N; McNamara R; Harkin A
    Br J Pharmacol; 2012 Nov; 167(5):946-59. PubMed ID: 22671762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific neurotoxicity of chronic use of ecstasy.
    Obrocki J; Schmoldt A; Buchert R; Andresen B; Petersen K; Thomasius R
    Toxicol Lett; 2002 Feb; 127(1-3):285-97. PubMed ID: 12052669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two ecstasy-induced myocardial infarctions during a three month period in a young man.
    Sadeghian S; Darvish S; Shahbazi S; Mahmoodian M
    Arch Iran Med; 2007 Jul; 10(3):409-12. PubMed ID: 17604486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ecstasy (MDMA) intoxication. An overview].
    Dinse H
    Anaesthesist; 1997 Aug; 46(8):697-703. PubMed ID: 9382208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration.
    McNamara R; Maginn M; Harkin A
    Eur J Pharmacol; 2007 Jan; 555(2-3):194-8. PubMed ID: 17126829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
    Dolan SB; Chen Z; Huang R; Gatch MB
    Neuropharmacology; 2018 May; 133():171-180. PubMed ID: 29378213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography.
    Obrocki J; Buchert R; Väterlein O; Thomasius R; Beyer W; Schiemann T
    Br J Psychiatry; 1999 Aug; 175():186-8. PubMed ID: 10627804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.